Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
J. Sven D. Mieog(Leiden University Medical Center), Gerrit‐Jan Liefers(Leiden University Medical Center), Peter J.K. Kuppen(Leiden University Medical Center), Esther Bastiaannet(University of Zurich), Anita Sajet(Leiden University Medical Center), Vincent T.H.B.M. Smit(Leiden University Medical Center), Anton JM de Craen(Leiden University Medical Center), Cornelis JH van de Velde(Leiden University), Esther M. de Kruijf(Leiden University Medical Center)
Cited by 39
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Micrometastases and Survival in Stage II Colorectal Cancer
|New England Journal of Medicine|1998|601
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
|Journal of Clinical Oncology|2010|540